Spherical nucleic acids show promise as a targeted and effective immunotherapy for patients with metastatic prostate cancer.
Third shot of COVID-19 vaccine not justified, says research
An expert review finds that booster shots for the general population are not yet necessary since vaccine efficacy against severe COVID-19 remains high.
Fridge-free COVID-19 vaccine candidates offer hope to billions
Two vaccines in early development are stable under high temperatures and could be game changers in global vaccine equity.
Graphene adjuvant improves efficacy of dendritic cell vaccines
Dendritic cell vaccines offer a unique opportunity in biomedicine, and limitations in efficacy can now potentially be overcome using graphene oxide nanosheets.
Could a universal coronavirus vaccine be possible?
COVID-19 is unlikely to be the last coronavirus to spill over to humans. Scientists are working to make a universal vaccine to combat future outbreaks.
Is “synonymous recoding” the future of vaccine development?
Large-scale recoding of virus genomes has the potential for use in vaccine design.
Improving one of medicine’s greatest inventions: Vaccines
Integrating vaccines with biomaterials could help minimize the need for refrigeration and booster shots.
What are mRNA vaccines?
With a long history of development, mRNA vaccines are finally making their debut and changing the face of the COVID-19 pandemic.
Why is there hype around the Novavax COVID-19 vaccine?
The protein-based vaccine has been highly anticipated, showing high efficacy against variants of concern.
Mixing COVID-19 vaccines might boost immunity
Emerging data from trials exploring mixing different types of vaccines demonstrate the practice is safe and could boost immunity.